A phase 1b study of step-up dosing with ABBV-383, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma Meeting Abstract
| Authors: | Mian, H.; Baljevic, M.; Magen, H.; Gatt, M. E.; Mazza, I. A.; Searle, E.; Lichtman, E. I.; McKay, J. T.; Plesner, T.; Rodriguez, C.; Korde, N.; Safah, H.; Vaxman, I.; Talati, C.; Svensson, A. E.; Jin, Z. Y.; Lee, S. E.; Doerr, T.; Pothacamury, R. K.; Rosenberg, T. S.; Polepally, A. R.; Ross, J. A.; Kumar, S. |
| Abstract Title: | A phase 1b study of step-up dosing with ABBV-383, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 1985 |
| Language: | English |
| ACCESSION: | WOS:001412856700009 |
| DOI: | 10.1182/blood-2024-206912 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
